ALZpath is a passionate and focused group of medical researchers, healthcare professionals, and renowned group of scientific advisors dedicated to transforming the Alzheimer’s disease ecosystem through earlier diagnosis, interventions, and personalized treatment to improve outcomes for people with Alzheimer’s.
Launching a novel blood-based biomarker assay for phosphorylated tau 217 (ptau217), ALZpath offers a simple, accessible, timely, and cost-effective approach to diagnosis, which is less invasive than current testing methods. Ptau217 in blood is considered one of the transformative AD diagnostic biomarker, which closely reflects amyloid and tau pathology, the hallmarks of AD, and associates with clinical features of AD.
Company Details
- Employees
- 11
- Address
- 2292 Faraday Ave, Carlsbad,california 92008,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://alzpath.bio
- Keywords
- New York.
- HQ
- Carlsbad, California
Alzpath Inc. Questions
Alzpath Inc.'s website is http://alzpath.bio
Alzpath Inc.'s LinkedIn profile is https://www.linkedin.com/company/alzpath-inc
Alzpath Inc. has
11 employees.
View email and phone details for 11
employees at Alzpath Inc..
Alzpath Inc.'s industry is
Biotechnology Research
Alzpath Inc.'s top competitors are
Sunbird Bio,
Nabla Bio,
Basecamp Research,
Mindahead,
C2n Diagnostics,
Alamar Biosciences, Inc.,
Alzheimer's Drug Discovery Foundation,
Io Biotech,
Protagonist Therapeutics,
Recursion.
Alzpath Inc.'s categories are Biotechnology Research
